Wedbush Reiterates AnaptysBio (ANAB) Outperform Recommendation
Fintel reports that on September 30, 2025, Wedbush reiterated coverage of AnaptysBio (NasdaqGS:ANAB) with a Outperform recommendation.
Analyst Price Forecast Suggests 55.28% Upside
As of September 30, 2025, the average one-year price target for AnaptysBio is $47.53/share. The forecasts range from a low of $20.20 to a high of $94.50. The average price target represents an increase of 55.28% from its latest reported closing price of $30.61 / share.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for AnaptysBio is 21MM, a decrease of 82.60%. The projected annual non-GAAP EPS is -4.36.
What is the Fund Sentiment?
There are 325 funds or institutions reporting positions in AnaptysBio. This is an decrease of 8 owner(s) or 2.40% in the last quarter. Average portfolio weight of all funds dedicated to ANAB is 0.17%, an increase of 6.31%. Total shares owned by institutions decreased in the last three months by 7.80% to 39,682K shares. 
The put/call ratio of ANAB is 1.31, indicating a bearish outlook.
What are Other Shareholders Doing?
EcoR1 Capital holds 7,880K shares representing 28.15% ownership of the company. No change in the last quarter.
First Light Asset Management holds 3,540K shares representing 12.64% ownership of the company. In its prior filing, the firm reported owning 4,634K shares , representing a decrease of 30.91%. The firm increased its portfolio allocation in ANAB by 3.57% over the last quarter.
Point72 Asset Management holds 2,475K shares representing 8.84% ownership of the company. In its prior filing, the firm reported owning 2,368K shares , representing an increase of 4.30%. The firm increased its portfolio allocation in ANAB by 7.31% over the last quarter.
Tang Capital Management holds 1,331K shares representing 4.75% ownership of the company. In its prior filing, the firm reported owning 1,545K shares , representing a decrease of 16.10%. The firm decreased its portfolio allocation in ANAB by 6.02% over the last quarter.
UBS Group holds 1,272K shares representing 4.55% ownership of the company. In its prior filing, the firm reported owning 490K shares , representing an increase of 61.47%. The firm increased its portfolio allocation in ANAB by 191.89% over the last quarter.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.